- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03142464
Intravenous Fluids After Laparoscopic Cholecystectomy
Intravenous Fluids After Laparoscopic Cholecystectomy: Necessary or Dispensable. A Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients undergoing elective laparoscopy cholecystectomies were randomized to either routine practice fluid prescription (control group) or no IV fluids in the postoperative period. Thirst, hunger, presence of nausea and vomiting, renal function and personal satisfaction were assessed.
Body composition was evaluated by bioimpedance
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: Elective laparoscopy cholescitectomy; no intraoperative complication -
Exclusion Criteria: Co-existing severe renal failure, cardiac failure or pulmonary disease
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: IV fluids
Regular IV fluids (Glucose 5% and Sodium Chloride 10% or Ringer) at the surgeon description
|
|
EXPERIMENTAL: No IV fluids
No IV fluids after the termination of the operation.
T
|
No IV fluids prescription, IV catheter filled with saline solution
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Renal function
Time Frame: 24 hours
|
Serum creatinine
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of thirst
Time Frame: 24 hours
|
Visual analog scale
|
24 hours
|
Presence of nausea
Time Frame: 24 hours
|
Visual analog scale
|
24 hours
|
Total intravenous prescribed fluids per body weight
Time Frame: 24 hours
|
24 hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 102908/2015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thirst
-
Universidade do PortoCompleted
-
Universidade do PortoCompleted
-
Gloucestershire Hospitals NHS Foundation TrustCompletedPostoperative ThirstUnited Kingdom
-
University of Sao PauloUniversidade Estadual de LondrinaCompleted
-
Universidade Estadual de LondrinaCompleted
-
University of California, San FranciscoCompleted
-
Universidade do PortoCompleted
-
National Taiwan University HospitalCompletedAnesthesia and ThirstTaiwan
-
University of Sao PauloUniversidade Estadual de LondrinaUnknownThirst | Perioperative NursingBrazil
-
Kahramanmaras Sutcu Imam UniversityCompleted
Clinical Trials on Suspension of the IV fluids
-
University of CalgaryMcGill University; University of Ottawa; Queen's University; Halton Health (Oakville) and other collaboratorsRecruiting
-
Stanford UniversityCompleted
-
Bnai Zion Medical CenterCompletedViral BronchiolitisIsrael
-
Samsung Medical CenterCompleted
-
University of CalgaryMedical University of South Carolina; University of Colorado, Denver; The Hospital... and other collaboratorsRecruitingHemolytic-Uremic Syndrome | Shiga Toxin-Producing Escherichia Coli (E. Coli) InfectionUnited States, Canada
-
Austin HealthCompletedCardiac SurgeryAustralia
-
The Hospital for Sick ChildrenCompleted
-
Massachusetts General HospitalMount Auburn Hospital; Pro EMSWithdrawn
-
Mt. Sinai Medical Center, MiamiFlorida Heart Research InstituteCompleted
-
Johns Hopkins UniversityWithdrawn